Results 101 to 110 of about 24,116 (179)

Comprehensive analysis of gp120 glycosylation to explore differences between transmitter/founder and chronic HIV-1 isolates. [PDF]

open access: yesGlycobiology
Temesy S   +11 more
europepmc   +1 more source

AS01<sub>B</sub>-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a <i>post-hoc</i> cross-protocol comparison of results from HVTN 100, 107, 120, and 702. [PDF]

open access: yesFront Immunol
Menezes F   +15 more
europepmc   +1 more source

Retraction Note: Neuroprotective effects of the Immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity. [PDF]

open access: yesJ Neuroinflammation
Fields JA   +9 more
europepmc   +1 more source

Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV. [PDF]

open access: yesJ Infect Dis
Benlarbi M   +11 more
europepmc   +1 more source

LncRNA SNHG1 Knockdown Ameliorates HIV-1 gp120V3 Loop-Induced Microglial Neuroinflammation by Regulating the Autophagy Process. [PDF]

open access: yesInflammation
Yan X   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy